Extra-pancreatic Incretin Effect, Glucose Effectiveness
Conditions
Brief summary
Incretin hormones (GLP-1 and GIP) released from the intestine in response to meal ingestion augment insulin secretion from the pancreas to help maintain glycemic control. Studies in vitro and in vivo have shown that these incretin hormones also have functional effects in other tissues independent of the insulin secretory response. Both GLP-1 and GIP stimulate insulin secretion in a glucose-dependent manner, however the glucose-dependency of their extra-pancreatic effects has not been examined in vivo. By using pancreatic clamp methodology during euglycemic and hyperglycemic conditions we will test the hypothesis that extra-pancreatic effects of GLP-1 and GIP are glucose-dependent.
Interventions
Sponsors
Rigshospitalet, Denmark
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE
Eligibility
Sex/Gender
MALE
Age
18 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
* age 18-60 years * BMI 18-30 kg/m2 * Male * Normal glycemic control (fasting glucose \<5.6 mM)
Exclusion criteria
* Evidence of chronic disease * Smoking * Active weight loss (\>2 kg in previous 6 months) * Treatment with drugs known to affect our outcome varaibles
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Glucose metabolism | up to 4 hours | Pancreatic clamp will be performed including infusion of somatostatin and replacement of basal insulin, glucagon, and growth hormone. During pancreatic clamps, euglycemia (5 mM) will be maintained via exogenous glucose infusion for the first 2-hours, followed by hyperglycemia (+5 mM) for the final 2-hours. An infusion of the stable isotope \[U13C\]glucose will be performed to assess glucose kinetics. Expired air will be collected for the analysis of \[U13C\]glucose into 13CO2. |
| Lipid metabolism | up to 4 hours | An infusion of the stable isotope \[D5\]glycerol will be performed to assess glycerol kinetics. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Endothelial function | Baseline, 2 hours, and 4 hours | Ultrasound Doppler will be used to examine lower and upper limb blood flow and flow-mediated dilation |
| Signaling | Baseline, 2 hours, and 4 hours | Skeletal muscle (vastus lateralis) and subcutaneous abdominal adipose biopsies will be obtained under local anaesthetic by the Bergstrom needle technique. Intracellular signalling related to glucose and lipid metabolism will be measured. |
Countries
Denmark
Outcome results
None listed